GL
BSX icon

Graypoint LLC’s Boston Scientific BSX Stock Holding History

Graypoint LLC’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.76M Buy
16,386
+1,371
+9% +$139K 0.1% 148
2025
Q1 		$1.51M Buy
15,015
+118
+0.8% +$11.9K 0.09% 149
2024
Q4 		$1.33M Buy
14,897
+550
+4% +$48.4K 0.08% 154
2024
Q3 		$1.2M Buy
14,347
+1,046
+8% +$82.5K 0.08% 172
2024
Q2 		$1.02M Buy
13,301
+663
+5% +$48.5K 0.07% 174
2024
Q1 		$866K Buy
12,638
+541
+4% +$34.8K 0.06% 192
2023
Q4 		$699K Buy
12,097
+6,349
+110% +$339K 0.06% 206
2023
Q3 		$303K Sell
5,748
-2,576
-31% -$135K 0.03% 332
2023
Q2 		$450K Buy
8,324
+2,925
+54% +$153K 0.04% 238
2023
Q1 		$270K Buy
+5,399
New +$254K 0.03% 296

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Graypoint LLC's BSX Position: Q2 2025 in Review

Graypoint LLC increased its Boston Scientific (BSX) stake by 9.1% in Q2 2025, buying an estimated $139K and bringing the position to 16,386 shares worth $1.76M. The position accounts for 0.1% of the portfolio, ranked #148.

Graypoint LLC first reported a position in BSX in Q1 2023 and has held it in 10 quarters since. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Graypoint LLC held 16,386 shares of Boston Scientific worth $1.76M as of Q2 2025.
  • Graypoint LLC bought 1,371 Boston Scientific shares in Q2 2025, an estimated $139K.
  • Boston Scientific made up 0.1% of Graypoint LLC's portfolio in Q2 2025, its #148 holding.
  • Graypoint LLC first reported a position in Boston Scientific in Q1 2023 and has held it in 10 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.